Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Hashimoto

Showing results (101-110 of 861) with videos related to

Pageof 87
Sort By:
The Open Medicinal Chemistry Journal|January 21, 2011
α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's DiseaseJun Toyohara, Kenji Hashimoto
The European Journal of Neuroscience|January 20, 2006
Slow oscillatory activity of rat globus pallidus neurons in vitroKenji Hashimoto, Hitoshi Kita
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|March 29, 2002
[Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs]Kenji Hashimoto, Masaomi Iyo
Plos One|February 8, 2019
Impact of consuming green and yellow vegetables on the depressive symptoms of junior and senior high school students in JapanMami Tanaka, Kenji Hashimoto
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 28, 2015
Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major DepressionChun Yang, Kenji Hashimoto
Expert Opinion on Investigational Drugs|June 6, 2015
Peripheral IL-6 signaling: a promising therapeutic target for depression?Chun Yang, Kenji Hashimoto
Annals of General Psychiatry|March 9, 2010
Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptorsTsutomu Furuse, Kenji Hashimoto
Biochimie|June 11, 2011
Calcium decoding mechanisms in plantsKenji Hashimoto, Jörg Kudla
Psychopharmacology|March 27, 2014
Rapid antidepressant effects and abuse liability of ketamineChun Yang, Kenji Hashimoto
Psychiatry Investigation|January 30, 2014
Benefical effects of sigma-1 agonist fluvoxamine for tardive dyskinesia and tardive akathisia in patients with schizophrenia: report of three casesYakup Albayrak, Kenji Hashimoto
Pageof 87

Showing results (101-110 of 861) with videos related to

Sort By:
Pageof 87
The Open Medicinal Chemistry Journal|January 21, 2011
α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's DiseaseJun Toyohara, Kenji Hashimoto
The European Journal of Neuroscience|January 20, 2006
Slow oscillatory activity of rat globus pallidus neurons in vitroKenji Hashimoto, Hitoshi Kita
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|March 29, 2002
[Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs]Kenji Hashimoto, Masaomi Iyo
Plos One|February 8, 2019
Impact of consuming green and yellow vegetables on the depressive symptoms of junior and senior high school students in JapanMami Tanaka, Kenji Hashimoto
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 28, 2015
Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major DepressionChun Yang, Kenji Hashimoto
Expert Opinion on Investigational Drugs|June 6, 2015
Peripheral IL-6 signaling: a promising therapeutic target for depression?Chun Yang, Kenji Hashimoto
Annals of General Psychiatry|March 9, 2010
Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptorsTsutomu Furuse, Kenji Hashimoto
Biochimie|June 11, 2011
Calcium decoding mechanisms in plantsKenji Hashimoto, Jörg Kudla
Psychopharmacology|March 27, 2014
Rapid antidepressant effects and abuse liability of ketamineChun Yang, Kenji Hashimoto
Psychiatry Investigation|January 30, 2014
Benefical effects of sigma-1 agonist fluvoxamine for tardive dyskinesia and tardive akathisia in patients with schizophrenia: report of three casesYakup Albayrak, Kenji Hashimoto
Pageof 87